PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Notice of Annual General Meeting/Proxy Form/Annual Report, page-53

  1. 3,064 Posts.
    lightbulb Created with Sketch. 553
    Yes, Ive reposted this in the more active thread for all to see.

    This is a joke.
    I know too well how it works having been involved in R&D, the concessions etc in the past.
    Keep writing those reports showing the fails along the way, that looks good for the R&D claims if they ever get audited because the auditors like to see fails along the way, it backs up that it was true R&D.
    Objective,
    Technical Challenges,
    Approach,
    Results.
    Bill for all the hrs, cough,cough. Write a report showing we knew this, wanted to achieve this, believed if we tried this then because of this its would result in x. But it didnt, hey presto, R&D refund.
    Rinse & Repeat. String the same project along for years.!!!
    Many R&D consultants out there that know how the system works and even guide you with the paperwork and then they take a % of what you get back as their fee.
    Easy money.!!!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.